News

23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company
Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.
23andMe's Founder Wins Bid For Bankrupt DNA Testing Firm
June 13 (Reuters) - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ REGN.O offer for the DNA-testing company ...
23andMe's Former CEO Anne Wojcicki Just Regained Control of the Company She Cofounded. Here's How.
TTAM replaces biotech company Regeneron as 23andMe's buyer. Last month, Regeneron won the bidding during the bankruptcy ...
Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...
Anne Wojcicki’s nonprofit wins bid to acquire genetic testing company 23andMe
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Former 23andMe CEO Outbids Big Pharma to Regain Control of DNA Testing Firm
Former 23andMe CEO Anne Wojcicki is set to regain control of the genetic testing firm she led to bankruptcy after outbidding a pharmaceutical company at an auction. The sale came on Monday after a ...